Chemical & Pharmaceutical Bulletin 1992-02-01

Studies on cardiac ingredients of plants. IX. Chemical transformation of proscillaridin by utilizing its 1,4-cycloadducts as key compounds and biological activities of their derivatives.

T Tanase, N Murakami, S Nagai, T Ueda, J Sakakibara, H Ando, Y Hotta, K Takeya

Index: Chem. Pharm. Bull. 40(2) , 327-32, (1992)

Full Text: HTML

Abstract

Three aromatic compounds (2-4) possessing a carbomethoxyl group or a dimethoxyphthaloyl group, prepared by the Diels-Alder reaction of the cardiac glycoside, proscillaridin (1), with dimethyl acetylenedicarboxylate and methyl propiolate, were transformed into alcohols, carboxylic acids and amides. The biological activities of the resulting derivatives were evaluated by the use of Na+, K(+)-adenosine triphosphatase (Na+,K(+)-ATPase) from dog kidney and isolated guinea-pig papillary muscle. Although the biological activities of the resulting derivatives were less potent than that of 1, a para-substituted benzylalcohol (5), methylbenzamides (9a and 10a), and ethylbenzamides (9b and 10b) inhibited the activity of Na+,K(+)-ATPase almost as potently as naturally occurring cardiac glycosides such as digoxin and digitoxin.


Related Compounds

Related Articles:

Pulse pressure correlates in humans with a proscillaridin A immunoreactive compound.

1996-05-01

[Hypertension 27(5) , 1073-8, (1996)]

Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs.

2009-11-01

[J. Nat. Prod. 72 , 1969-74, (2009)]

Role of endogenous cardiac glycosides in the spontaneously hypertensive rat--antagonism by active immunization.

1996-01-01

[Am. J. Hypertens. 9(1) , 81-5, (1996)]

Specific anti-digoxin Fab fragments: an available antidote for proscillaridin and scilliroside poisoning?

1990-05-01

[Hum. Exp. Toxicol. 9(3) , 191-3, (1990)]

Proscillaridin A immunoreactivity: its purification, transport in blood by a specific binding protein and its correlation with blood pressure.

1998-01-01

[Clin. Exp. Hypertens. 20(5-6) , 593-9, (1998)]

More Articles...